Femoston Conti 1mg/5mg Tablet is a combination hormone replacement therapy containing estradiol (1mg) and dydrogesterone (5mg), primarily used to manage symptoms associated with menopause. Estradiol, a form of estrogen, helps alleviate menopausal symptoms such as hot flashes, night sweats, vaginal dryness, and mood swings by restoring estrogen levels in the body. Dydrogesterone, a synthetic progestogen, complements estradiol by protecting the lining of the uterus (endometrium) from hyperplasia, which can occur when estrogen is administered alone. This balanced formulation is indicated for women who have not undergone a hysterectomy and require hormone replacement therapy for moderate to severe menopausal symptoms or prevention of osteoporosis post-menopause. Femoston Conti is typically prescribed as a continuous combined regimen, where both hormones are taken daily, promoting a regular menstrual cycle and reducing the risk of endometrial abnormalities. Patients should use this medication under medical supervision, as it may have contraindications in cases of hormone-sensitive cancers, thromboembolic disorders, liver disease, or unexplained vaginal bleeding. Regular follow-up is essential to monitor therapy effectiveness and side effects. Femoston Conti offers an effective option for improving quality of life in menopausal women by addressing hormonal imbalances safely and efficiently.